Showing 1 - 9 results of 9 for search 'Pi‐Hung Tung', query time: 0.04s Refine Results
  1. 1
    Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer

    Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung c... by Li‐Chung Chiu, Ping‐Chih Hsu, Chin‐Chou Wang, How‐Wen Ko, Scott Chih‐Hsi Kuo, Jia‐Shiuan Ju, Pi‐Hung Tung, Allen Chung‐Cheng Huang, Cheng‐Ta Yang

    Published 2024-03-01
    Get full text
    Article
  2. 2
    Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction

    Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction by Chiung-Hung Lin, Jih-Kai Yeh, Ting-Yu Lin, Yu-Lun Lo, Bo-Jui Chang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, Pi-Hung Tung, Yun-Ju Huang, Shu-Min Lin

    Published 2023-02-01
    Get full text
    Article
  3. 3
    A retrospective study of alectinib versus ceritinib in patients with advanced non–small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

    A retrospective study of alectinib versus ceritinib in patients with advanced non–small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed by Chih-Hsi Scott Kuo, Pi-Hung Tung, Allen Chung-Cheng Huang, Chin-Chou Wang, John Wen-Cheng Chang, Chien-Ying Liu, Fu-Tsai Chung, Yueh-Fu Fang, Yi-Ke Guo, Cheng-Ta Yang

    Published 2021-03-01
    Get full text
    Article
  4. 4
    The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study

    The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study by Ping-Chih Hsu, Chun-Yao Huang, Chin-Chou Wang, Scott Chih-Hsi Kuo, Chia-Hsun Chu, Pi-Hung Tung, Allen Chung-Cheng Huang, Chih-Liang Wang, Li-Chung Chiu, Yueh-Fu Fang, Cheng-Ta Yang

    Published 2020-10-01
    Get full text
    Article
  5. 5
    The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis

    The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis by Tzu-Hsuan Chiu, Pi-Hung Tung, Chi-Hsien Huang, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Chin-Chou Wang, Ho-Wen Ko, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang

    Published 2022-03-01
    Get full text
    Article
  6. 6
    Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

    Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC by Jia-Shiuan Ju, Allen Chung-Cheng Huang, Pi-Hung Tung, Chi-Hsien Huang, Tzu-Hsuan Chiu, Chin-Chou Wang, How-Wen Ko, Fu-Tsai Chung, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang

    Published 2023-11-01
    Get full text
    Article
  7. 7
    Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study

    Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clini... by Suey-Haur Lee, Yu-Ching Lin, Li-Chung Chiu, Jia-Shiuan Ju, Pi-Hung Tung, Allen Chung-Cheng Huang, Shih-Hong Li, Yueh-Fu Fang, Chih-Hung Chen, Scott Chih-Hsi Kuo, Chin-Chou Wang, Cheng-Ta Yang, Ping-Chih Hsu

    Published 2022-07-01
    Get full text
    Article
  8. 8
    Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

    Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC by Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang, Jia-Shiuan Ju, Chi-Hsien Huang, Chin-Chou Wang, How-Wen Ko, Fu-Tsai Chung, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang

    Published 2024-01-01
    Get full text
    Article
  9. 9
    Efficacy of portable sleep monitoring device in diagnosing central sleep apnea in patients with congestive heart failure

    Efficacy of portable sleep monitoring device in diagnosing central sleep apnea in patients with congestive heart failure by Pi-Hung Tung, Meng-Jer Hsieh, Meng-Jer Hsieh, Li-Pang Chuang, Li-Pang Chuang, Li-Pang Chuang, Shih-Wei Lin, Shih-Wei Lin, Kuo-Chun Hung, Cheng-Hui Lu, Wen-Chen Lee, Han-Chung Hu, Han-Chung Hu, Ming-Shien Wen, Ming-Shien Wen, Ning-Hung Chen, Ning-Hung Chen, Ning-Hung Chen

    Published 2022-12-01
    Get full text
    Article

Search Tools: